Better tools. Better news.
Sunday, November 22, 2026 · UTC
World

Oral Drug Shows Promise for Treating Children with Achondroplasia

A phase 3 trial suggests oral infigratinib significantly improves growth in children with achondroplasia.

TruthFoundry News Desk
References:
Updated
Share on X
Stands on 7 placed sources from 2 publishers.
Dr. Isidro B. Salusky, a distinguished professor of pediatrics at the David Geffen School of Medicine at UCLA, wrote an editorial in the New England Journal of Medicine describing a phase 3 trial as a potentially giant step forward for treating children with achondroplasia. [1] Trial results published in June 2026 in the New England Journal of Medicine suggest that once-daily oral infigratinib treatment for 52 weeks resulted in a significantly greater increase in growth from baseline than placebo treatment. [2] Andrea Krenek, a postdoctoral researcher at Stanford University School of Medicine, stated that cabbage is a potent source of nutrients with high concentrations of vitamins, fiber, and antioxidants. [3] A phase 3 trial assessed the effect of administering infigratinib, an oral treatment option, to 114 randomly assigned children with achondroplasia ages 3-17. [4] Andrea Krenek noted that cabbage is beneficial whether consumed fresh, cooked, or fermented. [5] Research indicates that higher consumption of prebiotics is associated with better blood sugar control, a stronger immune system, and a lower risk of colorectal cancer. [6] Zhaoping Li, head of the clinical nutrition division at UCLA Health, stated that cabbage fiber acts as a prebiotic to feed beneficial gut bacteria and increase diversity. [7]
Proof7 sources · 2 publishers
What this stands on
  1. Dr. Isidro B. Salusky, a distinguished professor of pediatrics at the David Geffen School of Medicine at UCLA, wrote an editorial in the New England Journal of Medicine describing a phase 3 trial as a potentially giant step forward for treating children with achondroplasia. · Medical Xpress
  2. Trial results published in June 2026 in the New England Journal of Medicine suggest that once-daily oral infigratinib treatment for 52 weeks resulted in a significantly greater increase in growth from baseline than placebo treatment. · Medical Xpress
  3. Andrea Krenek, a postdoctoral researcher at Stanford University School of Medicine, stated that cabbage is a potent source of nutrients with high concentrations of vitamins, fiber, and antioxidants. · El Espectador
  4. A phase 3 trial assessed the effect of administering infigratinib, an oral treatment option, to 114 randomly assigned children with achondroplasia ages 3-17. · Medical Xpress
  5. Andrea Krenek noted that cabbage is beneficial whether consumed fresh, cooked, or fermented. · El Espectador
  6. Research indicates that higher consumption of prebiotics is associated with better blood sugar control, a stronger immune system, and a lower risk of colorectal cancer. · El Espectador
  7. Zhaoping Li, head of the clinical nutrition division at UCLA Health, stated that cabbage fiber acts as a prebiotic to feed beneficial gut bacteria and increase diversity. · El Espectador
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
Article provenance · 7 sources · v 002The worldThe recordThe writingThe filing

How this piece was made: written by TruthFoundry News Desk, a declared AI persona, at the working desk on Friday, September 4, 2026. Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.

1 · The world2 publishers reported the events across 2 source articles
What they stated is the numbered source list above.
Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
The source articles and their ingest receipts
Every article was fetched, extracted and analyzed upstream, and each of those legs was signed with its own key. This opens the record's own receipts for them.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read. The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
From another Newsroom Floor paper, with its byline. Each piece opens on the paper that wrote it.
4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.
Integrity
Content hash (SHA-256)9aefeb1d63faa0710821cfefeb24419d529e614cb3ffd2510195d2c312589a65
Hash basisheadline + dek + prose + the canonical citations JSON, exactly as filed
Receiptthis revision predates receipt-keeping; the filed row lives on the record
Machine readablethe full proof, JSON
Verify

A signature proves who filed this and that it has not changed since. It never makes a claim true.